tiprankstipranks
Blueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
PremiumThe FlyBlueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
22d ago
Blueprint Medicines price target raised to $75 from $70 at Barclays
PremiumThe Fly
Blueprint Medicines price target raised to $75 from $70 at Barclays
22d ago
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
PremiumThe Fly
Blueprint Medicines price target raised to $114 from $99 at Oppenheimer
23d ago
Cogent Biosciences price target raised to $13 from $11 at Citi
PremiumThe FlyCogent Biosciences price target raised to $13 from $11 at Citi
3M ago
Blueprint Medicines announces PIONEER trial results
PremiumThe Fly
Blueprint Medicines announces PIONEER trial results
3M ago
Blueprint Medicines Divests GAVRETO Rights to Rigel
PremiumCompany Announcements
Blueprint Medicines Divests GAVRETO Rights to Rigel
3M ago
Blueprint Medicines price target raised to $99 from $90 at Oppenheimer
PremiumThe FlyBlueprint Medicines price target raised to $99 from $90 at Oppenheimer
3M ago
Blueprint Medicines provides 2024 financial guidance
PremiumThe Fly
Blueprint Medicines provides 2024 financial guidance
3M ago
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
PremiumPress Releases
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100